Skip to content

Can a brief cognitive intervention assist smokers in giving up?

Evaluation of the effectiveness of acceptance of the negative reinforcement explanation for smoking in facilitating smoking cessation: A cluster-randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65854845
Enrollment
140
Registered
2008-04-30
Start date
2008-06-02
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Smoking addiction

Interventions

Interventions: Both experimental and control interventions will be delivered as the last part of the pre-quit group session (week two of a seven-week course). They will consist either

Sponsors

Institute of Psychiatry, King's College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants must be attending for treatment at the NHS specialist smoking cessation clinic (SSCC) at The Royal London Hospital in East London. All clinic clients who provide informed consent and are able to fill in the study forms in English will be eligible.

Exclusion criteria

Exclusion criteria: Unable to fill in the study forms in English.

Design outcomes

Primary

MeasureTime frame
Urges to smoke and withdrawal symptoms, assessed using the Mood & Physical Symptoms Scale (T2 and T3) Timepoints: T0: At baseline, immediately prior to the first intervention session T1: Immediately following the first intervention session T2: One week later, immediately following the second intervention session T3: At follow-up one week following the second session

Secondary

MeasureTime frame
The following will be assessed by a 12-item questionnaire developed for the current research: 1. Participants' cognitions regarding the positive outcome expectations of smoking (T0, T1, T2, T3) 2. Expectations of the quitting process (T0, T1, T2, T3) 3. Self-efficacy (T0, T1, T2, T3) Timepoints: T0: At baseline, immediately prior to the first intervention session T1: Immediately following the first intervention session T2: One week later, immediately following the second intervention session T3: At follow-up one week following the second session

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026